Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms EMN Laurent, Y Sofianatos, A Komarova, JP Gimeno, PS Tehrani, DK Kim, ... BioRxiv, 2020.08. 28.272955, 2020 | 68 | 2020 |
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop Y Hua, G Vella, F Rambow, E Allen, AA Martinez, M Duhamel, A Takeda, ... Cancer Cell 40 (12), 1600-1618. e10, 2022 | 58 | 2022 |
Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification E Le Rhun, M Duhamel, M Wisztorski, JP Gimeno, F Zairi, F Escande, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1865 (7), 875-890, 2017 | 47 | 2017 |
Molecular consequences of proprotein convertase 1/3 (PC1/3) inhibition in macrophages for application to cancer immunotherapy: a proteomic study M Duhamel, F Rodet, N Delhem, FV Abeele, F Kobeissy, S Nataf, L Pays, ... Molecular & Cellular Proteomics 14 (11), 2857-2877, 2015 | 32 | 2015 |
Location of neonatal microglia drives small extracellular vesicles content and biological functions in vitro AN Murgoci, M Duhamel, A Raffo-Romero, K Mallah, S Aboulouard, ... Journal of Extracellular Vesicles 9 (1), 1727637, 2020 | 25 | 2020 |
Surfaceome proteomic of glioblastoma revealed potential targets for immunotherapy M Rose, T Cardon, S Aboulouard, N Hajjaji, F Kobeissy, M Duhamel, ... Frontiers in Immunology 12, 746168, 2021 | 23 | 2021 |
In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer S Aboulouard, M Wisztorski, M Duhamel, P Saudemont, T Cardon, ... Cell Reports Medicine 2 (6), 2021 | 21 | 2021 |
Real time and in vivo pharmaceutical and environmental studies with SpiderMass instrument B Fatou, P Saudemont, M Duhamel, M Ziskind, C Focsa, M Salzet, ... Journal of biotechnology 281, 61-66, 2018 | 20 | 2018 |
The role of proprotein convertases in the regulation of the function of immune cells in the oncoimmune response M Rose, M Duhamel, F Rodet, M Salzet Frontiers in Immunology 12, 667850, 2021 | 19 | 2021 |
Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival M Duhamel, L Drelich, M Wisztorski, S Aboulouard, JP Gimeno, N Ogrinc, ... Nature Communications 13 (1), 6665, 2022 | 17 | 2022 |
Reference and ghost proteins identification in rat C6 glioma extracellular vesicles AN Murgoci, T Cardon, S Aboulouard, M Duhamel, I Fournier, D Cizkova, ... Iscience 23 (5), 2020 | 16 | 2020 |
The role of a proprotein convertase inhibitor in reactivation of tumor-associated macrophages and inhibition of glioma growth M Rose, M Duhamel, S Aboulouard, F Kobeissy, E Le Rhun, A Desmons, ... Molecular Therapy-Oncolytics 17, 31-46, 2020 | 14 | 2020 |
The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways M Duhamel, F Rodet, AN Murgoci, R Desjardins, H Gagnon, M Wisztorski, ... Scientific reports 6 (1), 19360, 2016 | 14 | 2016 |
Paclitaxel treatment and proprotein convertase 1/3 (PC1/3) knockdown in macrophages is a promising antiglioma strategy as revealed by proteomics and cytotoxicity studies M Duhamel, M Rose, F Rodet, AN Murgoci, L Zografidou, ... Molecular & Cellular Proteomics 17 (6), 1126-1143, 2018 | 10 | 2018 |
Paclitaxel treatment and pc1/3 knockdown in macrophages is a promising anti-glioma strategy as revealed by proteomics and cytotoxicity studies M Duhamel, M Rose, F Rodet, AN Murgoci, L Zografidou, ... | 10 | 2018 |
Therapeutic anti-glioma effect of the combined action of PCSK inhibitor with the anti-tumoral factors secreted by Poly (I: C)-stimulated macrophages M Rose, M Duhamel, S Aboulouard, F Kobeissy, D Tierny, I Fournier, ... Cancer Gene Therapy 29 (1), 22-36, 2022 | 8 | 2022 |
PC1/3 KD macrophages exhibit resistance to the inhibitory effect of IL-10 and a higher TLR4 activation rate, leading to an anti-tumoral phenotype F Rodet, A Capuz, BA Ozcan, R Le Beillan, A Raffo-Romero, F Kobeissy, ... Cells 8 (12), 1490, 2019 | 8 | 2019 |
Deciphering molecular consequences of the proprotein convertase 1/3 inhibition in macrophages for application in anti-tumour immunotherapy F Rodet, A Capuz, T Hara, R Van Meel, M Duhamel, M Rose, ... Journal of biotechnology 282, 80-85, 2018 | 6 | 2018 |
METB-07classification of high grade glioma using matrix-assisted laser desorption/ionization mass spectrometry imaging (Maldi MSI): interim results of the gliomic study E Le Rhun, M Duhamel, M Wisztorski, F Zairi, CA Maurage, I Fournier, ... Neuro-oncology 17 (Suppl 5), v136, 2015 | 5 | 2015 |
Epigenetic Studies Revealed a Ghost Proteome in PC1/3 KD Macrophages under Antitumoral Resistance Induced by IL-10 T Cardon, B Ozcan, S Aboulouard, F Kobeissy, M Duhamel, F Rodet, ... ACS omega 5 (43), 27774-27782, 2020 | 4 | 2020 |